Related Experiment Video
Updated: May 27, 2026
08:20
In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
Published on: August 17, 2022
Vaccines for malaria: how close are we?
Mahamadou A Thera1, Christopher V Plowe
1Malaria Research and Training Center, Faculty of Medicine, University of Bamako, Bamako, Mali, West Africa. mthera@icermali.org
Annual Review of Medicine
|November 15, 2011
Summary
Developing a malaria vaccine is challenging due to the parasite's complexity. Promising new vaccines show moderate efficacy, with future strategies potentially involving whole parasite vaccines for better malaria control.
Area of Science:
- Immunology
- Infectious Diseases
- Vaccinology
Background:
- Vaccines are crucial public health tools, but developing a malaria vaccine has been historically challenging due to the parasite's complexity.
- Despite decades of research, a highly effective malaria vaccine remains elusive, hindering malaria control efforts.
Purpose of the Study:
- To review the progress and challenges in developing malaria vaccines.
- To discuss the potential of current and future malaria vaccine candidates.
Main Methods:
- Review of scientific literature on malaria vaccine development.
- Analysis of clinical trial data for leading malaria vaccine candidates.
Main Results:
- A subunit recombinant protein vaccine shows approximately 50% efficacy against clinical malaria in late-stage African trials.
- Incremental improvements to existing vaccine designs are feasible.
Conclusions:
- Licensed malaria vaccines are nearing reality, with current candidates offering moderate protection.
- Attenuated whole parasite vaccines combined with potent adjuvants may offer the best path toward highly efficacious vaccines and malaria eradication.
Related Concept Videos
01:51Vaccinations
Overview
00:58Symbiosis
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...